We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$27.2B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
+13.16%
1 Year Est. Return
+43.16%
3 Year Est. Return
+177.72%
5 Year Est. Return
+262.7%
10 Year Est. Return
+1,121.27%
AUM
$22.5B
AUM Growth
+$1.93B
(+9.4%)
Cap. Flow
+$256M
Cap. Flow
% of AUM
1.14%
Top 10 Holdings %
Top 10 Hldgs %
26.61%
Holding
1,346
New
164
Increased
337
Reduced
605
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$426M |
| 2 |
Deere & Co
DE
|
+$212M |
| 3 |
NVIDIA
NVDA
|
+$149M |
| 4 |
W.W. Grainger
GWW
|
+$140M |
| 5 |
Netflix
NFLX
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$196M |
| 2 |
Home Depot
HD
|
+$189M |
| 3 |
Gilead Sciences
GILD
|
+$145M |
| 4 |
Oracle
ORCL
|
+$145M |
| 5 |
Microsoft
MSFT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.24% |
| 2 | Financials | 13.5% |
| 3 | Healthcare | 12.02% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Industrials | 11.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
KB Home
KBH
$3.44B
| $393K | ﹤0.01% |
9,786
-1,093
| -10% | -$39.9K |
|
927
Cactus
WHD
$5.83B
| $393K | ﹤0.01% |
+9,535
| New | +$461K |
|
928
Bruker
BRKR
$8.88B
| $393K | ﹤0.01% |
4,983
-412
| -8% | -$29.7K |
|
929
MINISO
MNSO
$3.52B
| $393K | ﹤0.01% |
+22,144
| New | +$357K |
|
930
Enerpac Tool Group
EPAC
$1.89B
| $389K | ﹤0.01% |
+15,270
| New | +$403K |
|
931
Porch Group
PRCH
$1.9B
| $389K | ﹤0.01% |
272,240
-54,460
| -17% | -$129K |
|
932
Alcoa
AA
$13.3B
| $389K | ﹤0.01% |
+9,134
| New | +$440K |
|
933
Kosmos Energy
KOS
$1.49B
| $389K | ﹤0.01% |
52,220
-4,141
| -7% | -$30.3K |
|
934
Fluor
FLR
$7B
| $388K | ﹤0.01% |
+12,549
| New | +$432K |
|
|
PETQ
935
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $388K | ﹤0.01% |
33,886
+4,991
| +17% | +$55.4K |
|
936
Carter Bankshares
CARE
$759M
| $388K | ﹤0.01% |
27,687
-680
| -2% | -$11K |
|
|
EXAS
937
DELISTED
Exact Sciences
EXAS
| $382K | ﹤0.01% |
+5,640
| New | +$363K |
|
938
Steven Madden
SHOO
$3.46B
| $382K | ﹤0.01% |
10,616
-1,089
| -9% | -$37.7K |
|
|
AVDX
939
DELISTED
AvidXchange
AVDX
| $382K | ﹤0.01% |
48,943
-2,072
| -4% | -$19.9K |
|
940
Coherent
COHR
$65.3B
| $382K | ﹤0.01% |
10,021
| – | – |
|
941
MaxLinear
MXL
$7.03B
| $380K | ﹤0.01% |
10,803
-59,636
| -85% | -$2.16M |
|
942
Orion
OEC
$365M
| $376K | ﹤0.01% |
+14,416
| New | +$326K |
|
943
Onto Innovation
ONTO
$20.8B
| $376K | ﹤0.01% |
4,279
+699
| +20% | +$56.7K |
|
|
ALTR
944
DELISTED
Altair Engineering Inc
ALTR
| $375K | ﹤0.01% |
+5,203
| New | +$307K |
|
|
DSEY
945
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
| $375K | ﹤0.01% |
+46,313
| New | +$294K |
|
946
Fox Factory Holding Corp
FOXF
$891M
| $374K | ﹤0.01% |
3,084
-229
| -7% | -$26.3K |
|
947
First Advantage
FA
$3.77B
| $372K | ﹤0.01% |
26,627
-1,292
| -5% | -$17.5K |
|
|
VISN
948
Vistance Networks Inc
VISN
$2.68B
| $371K | ﹤0.01% |
+58,262
| New | +$441K |
|
|
EHAB
949
DELISTED
Enhabit
EHAB
| $371K | ﹤0.01% |
26,663
-24,401
| -48% | -$351K |
|
950
Intellia Therapeutics
NTLA
$1.66B
| $369K | ﹤0.01% |
9,901
-762
| -7% | -$29.9K |
|
Similar funds
FDCDDQ
WP
N
PCH
VAI
Los Angeles Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Los Angeles Capital Management held 1,346 positions worth $22.5B, up 9.4% from $20.6B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Los Angeles Capital Management's Q1 2023 filing shows 164 new, 337 increased, 605 reduced and 194 closed positions. Its largest new stake was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M. The largest sale was Pfizer, an estimated $196M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- Los Angeles Capital Management's largest Q1 2023 buy was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M.
- Los Angeles Capital Management added most to Visa in Q1 2023, an estimated $426M increase.
- Los Angeles Capital Management's biggest Q1 2023 reduction was Pfizer, cutting an estimated $196M.
- Los Angeles Capital Management fully exited Regions Financial in Q1 2023, selling an estimated $50.4M.
- Los Angeles Capital Management's ten largest holdings make up 27% of its $22.5B portfolio in Q1 2023.
- Los Angeles Capital Management opened 164 new positions and closed 194 in Q1 2023.
- Los Angeles Capital Management's portfolio value rose 9.4% quarter-over-quarter to $22.5B.
Based on Los Angeles Capital Management's 13F filing for Q1 2023, filed 4 May 2023.